Product Code: A08198
The digestive enzymes market was valued at $699.4 million in 2021, and is projected to reach $1,643.6 million by 2031, registering a CAGR of 8.7% from 2022 to 2031.
Digestive enzymes break down proteins, carbohydrates, and lipids and their supplementation play a role in management of digestive disorders, from lactose intolerance to cystic fibrosis. Several formulations of digestive enzymes are available in the market, being different from each other in terms of enzyme type, source & origin, and dosage. Animals-derived enzymes represent an established standard of care. However, the growing study of plants-based and microbe-derived enzymes offer great advancements of digestive enzyme therapy. Moreover, pancreatic enzyme supplementation is the therapy of choice for management of exocrine pancreatic insufficiency (EPI) in chronic pancreatitis, pancreatic cancer, cystic fibrosis (CF), or diabetes. Required daily dose of enzymes is variable, being related to etiology and severity of clinical features of patients, such as age & body weight and for cystic fibrosis, genotype and intestinal factors affect absorption.
The digestive enzymes market trends like increase in prevalence of digestive problems, increase in unhealthy lifestyle by population, and rise in geriatric population are key factors that fuel growth of the digestive enzyme market. Moreover, surge in number of fitness centers and gymnasiums has also increased demand for dietary supplements, increase in awareness about GI health, and focus on preventive disease management are other factors that contribute toward growth of the market. However, lack of knowledge regarding appropriate dosage amounts and presence of substitutes for digestive enzyme supplements are expected to hinder growth of the market. Conversely, development of customized digestive enzymes offer lucrative opportunities for growth of the market.
The digestive enzymes market is segmented into origin, enzyme type, application, and region. By origin, the market is categorized into animals, microbial, and plants. Further, the animals segment is categorized into prescription medicine, sports nutrition, and infant nutrition. The sports nutrition segment for animals is classified into sports drink and other sport supplements. Further, the microbial segment is categorized into prescription medicine, sports nutrition, and infant nutrition. In addition, the sports nutrition segment for microbial is classified into sports drink and other sport supplements. The plants segment is further categorized into prescription medicine, sports nutrition, and infant nutrition. The sports nutrition for plants is classified into sports drink and other sport supplements. By enzyme type, the market is divided into carbohydrase, protease, lipase, and others. By application, it is divided into prescription medicine, sports nutrition, and infant nutrition. Region wise, the market is analyzed across North America (U.S., Canada, and Mexico), Europe (Germany, France, UK, Italy, Spain, and rest of Europe), Asia-Pacific (Japan, China, Australia, India, South Korea and Rest of Asia-Pacific), and LAMEA (Brazil, South Africa, Saudi Arabia, and Rest of LAMEA).
Major companies profiled in the report include Abbott Laboratories, AbbVie Inc., Amway Corporation, Archer Daniels Midland Company, Biotics Research Corporation, Brain Group Co Ltd., Country Life, LLC, Douglas Laboratories, Garden of Life, International Flavors & Fragrances Inc, Johnson & Johnson, Metagenics Inc., Mimi's Rock Corporation, Otsuka Holding Co ltd, Soho Flordis International Health, The Enzymedica Group, Vox Nutrition.
Key Benefits For Stakeholders
- This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the digestive enzymes market analysis from 2021 to 2031 to identify the prevailing digestive enzymes market opportunities.
- The market research is offered along with information related to key drivers, restraints, and opportunities.
- Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
- In-depth analysis of the digestive enzymes market segmentation assists to determine the prevailing market opportunities.
- Major countries in each region are mapped according to their revenue contribution to the global market.
- Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
- The report includes the analysis of the regional as well as global digestive enzymes market trends, key players, market segments, application areas, and market growth strategies.
Key Market Segments
By Origin
By Enzyme Type
- Carbohydrase
- Protease
- Lipase
- Other Enzyme Types
By Applications
- Prescription Medicine
- Sports Nutrition
- Infant Nutrition
By Region
- North America
- Europe
- Germany
- France
- U.K.
- Italy
- Spain
- Rest of Europe
- Asia-Pacific
- Japan
- China
- India
- Australia
- South Korea
- Rest of Asia-Pacific
- LAMEA
- Brazil
- Saudi Arabia
- South Africa
- Rest of LAMEA
- Key Market Players
- Allergan PLC
- Abbvie Inc.
- Amway Corporation
- Country Life LLC.
- Garden Of Life Inc.
- Biotics Research Corporation
- Metagenics, Inc.
- Abbott Nutrition.
- Johnson & Johnson
- Archer Daniels Midland Company (DeerLand Enzymes)
TABLE OF CONTENTS
CHAPTER 1:INTRODUCTION
- 1.1.Report description
- 1.2.Key market segments
- 1.3.Key benefits to the stakeholders
- 1.4.Research Methodology
- 1.4.1.Secondary research
- 1.4.2.Primary research
- 1.4.3.Analyst tools and models
CHAPTER 2:EXECUTIVE SUMMARY
- 2.1.Key findings of the study
- 2.2.CXO Perspective
CHAPTER 3:MARKET OVERVIEW
- 3.1.Market definition and scope
- 3.2.Key findings
- 3.2.1.Top investment pockets
- 3.3.Porter's five forces analysis
- 3.4.Top player positioning
- 3.5.Market dynamics
- 3.5.1.Drivers
- 3.5.2.Restraints
- 3.5.3.Opportunities
- 3.6.COVID-19 Impact Analysis on the market
CHAPTER 4: DIGESTIVE ENZYMES MARKET, BY ORIGIN
- 4.1 Overview
- 4.1.1 Market size and forecast
- 4.2 Animal
- 4.2.1 Key market trends, growth factors and opportunities
- 4.2.2 Market size and forecast, by region
- 4.2.3 Market analysis by country
- 4.3 Microbial
- 4.3.1 Key market trends, growth factors and opportunities
- 4.3.2 Market size and forecast, by region
- 4.3.3 Market analysis by country
- 4.4 Plant
- 4.4.1 Key market trends, growth factors and opportunities
- 4.4.2 Market size and forecast, by region
- 4.4.3 Market analysis by country
CHAPTER 5: DIGESTIVE ENZYMES MARKET, BY ENZYME TYPE
- 5.1 Overview
- 5.1.1 Market size and forecast
- 5.2 Carbohydrase
- 5.2.1 Key market trends, growth factors and opportunities
- 5.2.2 Market size and forecast, by region
- 5.2.3 Market analysis by country
- 5.3 Protease
- 5.3.1 Key market trends, growth factors and opportunities
- 5.3.2 Market size and forecast, by region
- 5.3.3 Market analysis by country
- 5.4 Lipase
- 5.4.1 Key market trends, growth factors and opportunities
- 5.4.2 Market size and forecast, by region
- 5.4.3 Market analysis by country
- 5.5 Other Enzyme Types
- 5.5.1 Key market trends, growth factors and opportunities
- 5.5.2 Market size and forecast, by region
- 5.5.3 Market analysis by country
CHAPTER 6: DIGESTIVE ENZYMES MARKET, BY APPLICATIONS
- 6.1 Overview
- 6.1.1 Market size and forecast
- 6.2 Prescription Medicine
- 6.2.1 Key market trends, growth factors and opportunities
- 6.2.2 Market size and forecast, by region
- 6.2.3 Market analysis by country
- 6.3 Sports Nutrition
- 6.3.1 Key market trends, growth factors and opportunities
- 6.3.2 Market size and forecast, by region
- 6.3.3 Market analysis by country
- 6.4 Infant Nutrition
- 6.4.1 Key market trends, growth factors and opportunities
- 6.4.2 Market size and forecast, by region
- 6.4.3 Market analysis by country
CHAPTER 7: DIGESTIVE ENZYMES MARKET, BY REGION
- 7.1 Overview
- 7.1.1 Market size and forecast
- 7.2 North America
- 7.2.1 Key trends and opportunities
- 7.2.2 North America Market size and forecast, by Origin
- 7.2.3 North America Market size and forecast, by Enzyme Type
- 7.2.4 North America Market size and forecast, by Applications
- 7.2.5 North America Market size and forecast, by country
- 7.2.5.1 U.S.
- 7.2.5.1.1 Market size and forecast, by Origin
- 7.2.5.1.2 Market size and forecast, by Enzyme Type
- 7.2.5.1.3 Market size and forecast, by Applications
- 7.2.5.2 Canada
- 7.2.5.2.1 Market size and forecast, by Origin
- 7.2.5.2.2 Market size and forecast, by Enzyme Type
- 7.2.5.2.3 Market size and forecast, by Applications
- 7.2.5.3 Mexico
- 7.2.5.3.1 Market size and forecast, by Origin
- 7.2.5.3.2 Market size and forecast, by Enzyme Type
- 7.2.5.3.3 Market size and forecast, by Applications
- 7.3 Europe
- 7.3.1 Key trends and opportunities
- 7.3.2 Europe Market size and forecast, by Origin
- 7.3.3 Europe Market size and forecast, by Enzyme Type
- 7.3.4 Europe Market size and forecast, by Applications
- 7.3.5 Europe Market size and forecast, by country
- 7.3.5.1 Germany
- 7.3.5.1.1 Market size and forecast, by Origin
- 7.3.5.1.2 Market size and forecast, by Enzyme Type
- 7.3.5.1.3 Market size and forecast, by Applications
- 7.3.5.2 France
- 7.3.5.2.1 Market size and forecast, by Origin
- 7.3.5.2.2 Market size and forecast, by Enzyme Type
- 7.3.5.2.3 Market size and forecast, by Applications
- 7.3.5.3 U.K.
- 7.3.5.3.1 Market size and forecast, by Origin
- 7.3.5.3.2 Market size and forecast, by Enzyme Type
- 7.3.5.3.3 Market size and forecast, by Applications
- 7.3.5.4 Italy
- 7.3.5.4.1 Market size and forecast, by Origin
- 7.3.5.4.2 Market size and forecast, by Enzyme Type
- 7.3.5.4.3 Market size and forecast, by Applications
- 7.3.5.5 Spain
- 7.3.5.5.1 Market size and forecast, by Origin
- 7.3.5.5.2 Market size and forecast, by Enzyme Type
- 7.3.5.5.3 Market size and forecast, by Applications
- 7.3.5.6 Rest of Europe
- 7.3.5.6.1 Market size and forecast, by Origin
- 7.3.5.6.2 Market size and forecast, by Enzyme Type
- 7.3.5.6.3 Market size and forecast, by Applications
- 7.4 Asia-Pacific
- 7.4.1 Key trends and opportunities
- 7.4.2 Asia-Pacific Market size and forecast, by Origin
- 7.4.3 Asia-Pacific Market size and forecast, by Enzyme Type
- 7.4.4 Asia-Pacific Market size and forecast, by Applications
- 7.4.5 Asia-Pacific Market size and forecast, by country
- 7.4.5.1 Japan
- 7.4.5.1.1 Market size and forecast, by Origin
- 7.4.5.1.2 Market size and forecast, by Enzyme Type
- 7.4.5.1.3 Market size and forecast, by Applications
- 7.4.5.2 China
- 7.4.5.2.1 Market size and forecast, by Origin
- 7.4.5.2.2 Market size and forecast, by Enzyme Type
- 7.4.5.2.3 Market size and forecast, by Applications
- 7.4.5.3 India
- 7.4.5.3.1 Market size and forecast, by Origin
- 7.4.5.3.2 Market size and forecast, by Enzyme Type
- 7.4.5.3.3 Market size and forecast, by Applications
- 7.4.5.4 Australia
- 7.4.5.4.1 Market size and forecast, by Origin
- 7.4.5.4.2 Market size and forecast, by Enzyme Type
- 7.4.5.4.3 Market size and forecast, by Applications
- 7.4.5.5 South Korea
- 7.4.5.5.1 Market size and forecast, by Origin
- 7.4.5.5.2 Market size and forecast, by Enzyme Type
- 7.4.5.5.3 Market size and forecast, by Applications
- 7.4.5.6 Rest of Asia-Pacific
- 7.4.5.6.1 Market size and forecast, by Origin
- 7.4.5.6.2 Market size and forecast, by Enzyme Type
- 7.4.5.6.3 Market size and forecast, by Applications
- 7.5 LAMEA
- 7.5.1 Key trends and opportunities
- 7.5.2 LAMEA Market size and forecast, by Origin
- 7.5.3 LAMEA Market size and forecast, by Enzyme Type
- 7.5.4 LAMEA Market size and forecast, by Applications
- 7.5.5 LAMEA Market size and forecast, by country
- 7.5.5.1 Brazil
- 7.5.5.1.1 Market size and forecast, by Origin
- 7.5.5.1.2 Market size and forecast, by Enzyme Type
- 7.5.5.1.3 Market size and forecast, by Applications
- 7.5.5.2 Saudi Arabia
- 7.5.5.2.1 Market size and forecast, by Origin
- 7.5.5.2.2 Market size and forecast, by Enzyme Type
- 7.5.5.2.3 Market size and forecast, by Applications
- 7.5.5.3 South Africa
- 7.5.5.3.1 Market size and forecast, by Origin
- 7.5.5.3.2 Market size and forecast, by Enzyme Type
- 7.5.5.3.3 Market size and forecast, by Applications
- 7.5.5.4 Rest of LAMEA
- 7.5.5.4.1 Market size and forecast, by Origin
- 7.5.5.4.2 Market size and forecast, by Enzyme Type
- 7.5.5.4.3 Market size and forecast, by Applications
CHAPTER 8: COMPANY LANDSCAPE
- 8.1. Introduction
- 8.2. Top winning strategies
- 8.3. Product Mapping of Top 10 Player
- 8.4. Competitive Dashboard
- 8.5. Competitive Heatmap
- 8.6. Key developments
CHAPTER 9: COMPANY PROFILES
- 9.1 Allergan PLC
- 9.1.1 Company overview
- 9.1.2 Company snapshot
- 9.1.3 Operating business segments
- 9.1.4 Product portfolio
- 9.1.5 Business performance
- 9.1.6 Key strategic moves and developments
- 9.2 Abbvie Inc.
- 9.2.1 Company overview
- 9.2.2 Company snapshot
- 9.2.3 Operating business segments
- 9.2.4 Product portfolio
- 9.2.5 Business performance
- 9.2.6 Key strategic moves and developments
- 9.3 Amway Corporation
- 9.3.1 Company overview
- 9.3.2 Company snapshot
- 9.3.3 Operating business segments
- 9.3.4 Product portfolio
- 9.3.5 Business performance
- 9.3.6 Key strategic moves and developments
- 9.4 Country Life LLC.
- 9.4.1 Company overview
- 9.4.2 Company snapshot
- 9.4.3 Operating business segments
- 9.4.4 Product portfolio
- 9.4.5 Business performance
- 9.4.6 Key strategic moves and developments
- 9.5 Garden Of Life Inc.
- 9.5.1 Company overview
- 9.5.2 Company snapshot
- 9.5.3 Operating business segments
- 9.5.4 Product portfolio
- 9.5.5 Business performance
- 9.5.6 Key strategic moves and developments
- 9.6 Biotics Research Corporation
- 9.6.1 Company overview
- 9.6.2 Company snapshot
- 9.6.3 Operating business segments
- 9.6.4 Product portfolio
- 9.6.5 Business performance
- 9.6.6 Key strategic moves and developments
- 9.7 Metagenics, Inc.
- 9.7.1 Company overview
- 9.7.2 Company snapshot
- 9.7.3 Operating business segments
- 9.7.4 Product portfolio
- 9.7.5 Business performance
- 9.7.6 Key strategic moves and developments
- 9.8 Abbott Nutrition.
- 9.8.1 Company overview
- 9.8.2 Company snapshot
- 9.8.3 Operating business segments
- 9.8.4 Product portfolio
- 9.8.5 Business performance
- 9.8.6 Key strategic moves and developments
- 9.9 Johnson & Johnson
- 9.9.1 Company overview
- 9.9.2 Company snapshot
- 9.9.3 Operating business segments
- 9.9.4 Product portfolio
- 9.9.5 Business performance
- 9.9.6 Key strategic moves and developments
- 9.10 Archer Daniels Midland Company (DeerLand Enzymes)
- 9.10.1 Company overview
- 9.10.2 Company snapshot
- 9.10.3 Operating business segments
- 9.10.4 Product portfolio
- 9.10.5 Business performance
- 9.10.6 Key strategic moves and developments